CIPLA Share Price Performance
₹0
-1465.50 (-100.00%)
Price ₹0
Fair Value₹1,677.33
Share Pricen/a
Does Cipla (NSE:CIPLA) Deserve A Spot On Your Watchlist?
Nov 20
Cipla Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 38 Fair Values set on narratives written by author
CIPLA Community Narratives
AN
Fair Value ₹1.68k 9.9% undervalued intrinsic discount
Emerging Markets And Chronic Therapies Will Open New Horizons
0users have liked this narrative
0users have commented on this narrative
25users have followed this narrative
Emerging Markets And Chronic Therapies Will Open New Horizons
Key Takeaways Expansion in chronic therapies and complex generics, combined with digital and e-pharmacy investments, drives sustainable revenue and margin growth across key global markets. Manufacturing self-reliance and compliance strengths position Cipla to capitalize on supply chain shifts and localization trends, supporting long-term profitability and export growth.Read more
0users have liked this narrative
0users have commented on this narrative
25users have followed this narrative
AN
₹1.68k
9.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
8.36% p.a.
Profit Margin
15.92%
Future PE
34.88x
Share price in 2028
₹2.4k
Recently Updated Narratives
AN
Emerging Markets And Chronic Therapies Will Open New Horizons
Fair Value: ₹1.68k 9.9% undervalued intrinsic discount
25 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Flawless balance sheet with solid track record and pays a dividend.
0 Risks
4 Rewards
Cipla Limited Key Details
About CIPLA
- Founded
- 1935
- Employees
- 30313
- CEO
- WebsiteView website
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
